New insider activity at Labcorp Holdings ( (LH) ) has taken place on February 28, 2025.
Sandra D van der Vaart, the Executive Vice President and Chief Legal Officer of Labcorp Holdings, recently sold 1,314 shares of the company’s stock. This transaction was valued at $330,208, indicating a significant divestment by a key executive.
Recent Updates on LH stock
Labcorp Holdings has seen several price target adjustments from analysts following its recent earnings report and strategic developments. Piper Sandler raised its price target due to the company’s quarterly results, maintaining a neutral rating. Deutsche Bank also increased its target, citing the in-line Q4 report, while maintaining a hold rating. Baird adjusted its model after the Q4 results, raising its target and keeping an outperform rating. The company’s earnings call highlighted strong revenue growth in diagnostics and biopharma, strategic acquisitions, and collaborations, despite concerns over margin pressures and increased personnel costs. Labcorp’s positive financial performance and optimistic future guidance have contributed to these target changes.
More about Labcorp Holdings
YTD Price Performance: 10.46%
Average Trading Volume: 540,967
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $21.1B